Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease

Published:2016-03-05 Issue:5 Volume:129 Page:562-569
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Huang Rong-Shuang,Cheng Yi-Ming,Zeng Xiao-Xi,Kim Sehee,Fu Ping

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group;Locatelli;Nephrol Dial Transplant,1996

2. Proteinuria as a risk factor for cardiovascular disease and mortality in older people:A prospective study;Culleton;Am J Med,2000

3. Renal protection in hypertensive patients: Selection of antihypertensive therapy;Wenzel;Drugs,2005

4. Angiotensin converting enzyme inhibitors and calcium antagonists: A synergistic action for a better prevention of cardiovascular events;Boutouyrie;Therapie,2009

5. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target;Mourad;Vasc Health Risk Manag,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01

2. Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial;Cureus;2023-03-07

3. First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency;Heliyon;2022-11

4. Rising serum potassium and creatinine concentrations after prescribing renin–angiotensin–aldosterone system blockade: how much should we worry?;World Journal of Pediatrics;2021-09-02

5. Dihydropyridine calcium channel blockers for the renoprotective therapy of hypertensive patients with chronic kidney disease;Nephrology (Saint-Petersburg);2021-02-13